Ansa Capital
177 Lafayette St, 600N, New York, NY, 10013, United States
Overview
Ansa is an expansion-stage investment fund built to support founders as they scale. Our focus is on new markets, innovative distribution models, and modernizing legacy systems, serving as the hub of tomorrow’s leading companies, operators and ideas. Our team and community of functional operators bring diverse perspectives and resources to bear, helping the next generation of leaders win.
- Total investments
- 10
- Lead investments
- 6
- Investments · 12mo
- 4
- Active investors
- 2
Investment portfolio
- Coram AI
Led · Series B · Jun 2026
Coram AI offers an AI-native platform that integrates video security, access control, guest management, and emergency workflows to modernize physical security without replacing existing cameras and infrastructure. Since its $13.8 million Series A last year, Coram reports a 4x increase in revenue and a tripling of its customer base, now protecting more than 1,500 sites across the U.S. and Canada including Fortune 500s and large school districts, healthcare providers, manufacturers, and municipalities. The company is introducing capabilities called Deep Investigation that analyze video, access events, and visitor activity across cameras, locations, and time to answer complex security questions with attached evidence. Coram says these autonomous investigation capabilities reduce investigation times from hours or weeks to minutes, enabling smaller teams to handle more incidents. The company plans to use new funding to expand sales capacity and continue investments in AI product development and customer success, and is actively hiring across multiple functions.
- Selector
Participated · Equity · Feb 2026
Selector offers a unified observability and network intelligence solution that integrates large language models, knowledge graphs, and causal reasoning to deliver real-time root-cause analysis, predictive maintenance, and automated remediation. The platform replaces siloed monitoring tools with a single pane of glass, giving operations teams contextual insights across cloud, network, and application layers. In 2025 the company’s cumulative annual recurring revenue reached 230 % of 2024 levels, marking its fourth consecutive year of doubling ARR, and new ARR booked jumped to 370 % of 2024. Approximately 80 % of its customers are Fortune 1000 firms, including three new Fortune 20 customers in manufacturing and healthcare. Selector has expanded globally via cloud marketplaces, regional partners, and an initial push into Japan. The firm recently secured eight foundational U.S. patents covering LLM training, causal inference, and network path intelligence, and it plans to launch an enhanced Agentic ChatOps capability for multi-turn reasoning. Headquartered in Santa Clara, Selector is backed by a roster of telecom and enterprise-focused investors.
- Synthpop
Led · Series A · Feb 2026
Founded in 2023 and headquartered in Cambridge, Massachusetts, Synthpop offers an API-first, multi-agent system that combines document intelligence, payer-aware reasoning, conversational voice agents, and an orchestration layer to streamline healthcare administration. The platform integrates directly with EHR, billing, and e-prescribe systems and can automate up to 80 % of business processes such as referrals, prior authorizations, eligibility checks, claims follow-ups, and other patient-access tasks. In production, Synthpop has already processed data for more than 2 million patients and connects with eight major EHR platforms. Customers report that workflows once taking 40 minutes are now completed in under a minute at a cost roughly five times lower than traditional human labor while maintaining full compliance. The company is SOC 2-audited and HIPAA-compliant, positioning it as a secure infrastructure provider within the healthcare ecosystem. With its latest funding, Synthpop plans to expand its team, deepen product capabilities, and move into additional healthcare verticals. Total funding to date stands at $23 million.
- Defense Unicorns
Participated · Series B · Jan 2026
Founded in 2021 by veteran technologists Rob Slaughter, Jeff McCoy, and Andrew Greene, San Antonio-based Defense Unicorns builds open-source, airgap-native platforms that enable secure development, delivery, and sustainment of mission software across cloud, on-premises, and tactical edge environments. Its flagship Unicorn Delivery Service (UDS) gives warfighters the ability to deploy and update software on submarines, ships, aircraft, and forward operating bases with minimal or no connectivity. Complementary products such as UDS Registry and UDS Army extend secure DevSecOps pipelines and supply-chain protection to allied forces and commercial vendors. Adoption of the company’s technology in military systems has grown 300% year-over-year, and the business is already profitable. With fresh capital, Defense Unicorns plans to further scale its platform and integrate additional dual-use technologies across U.S. and allied defense networks. The firm’s technology is trusted by the Navy, Army, Air Force, and Space Force, positioning it as foundational infrastructure for modern national security software. The recent financing places the company’s valuation above $1 billion, marking it as a defense tech unicorn.
- SpecterOps
Participated · Series B · Mar 2025
SpecterOps builds adversary-focused cybersecurity products and services that help organizations detect and remove Identity-based Attack Paths, centered on its BloodHound open-source project and BloodHound Enterprise (BHE) managed SaaS. BHE, launched in 2021, provides attack path prioritization, remediation guidance and reporting for Active Directory, Entra ID and hybrid environments. The company emphasizes research and community contributions—BloodHound has been downloaded more than 1.5 million times and SpecterOps has produced 90+ open-source security tools and trained over 7,000 students. In 2024 SpecterOps reported ARR growth of 100% year-over-year and grew new customer acquisition over 60% YoY in Q4 to nearly 200 BHE customers. Recent milestones include FedRAMP High Authorization for BHE in December 2024 and CREST accreditation for penetration testing in January 2025, along with launching a channel partner program and additions to its board. SpecterOps builds adversary-focused cybersecurity solutions, centered on BloodHound Enterprise (BHE), a platform for removing identity attack paths in Active Directory and Azure AD. The company also maintains BloodHound free and open-source software, with the most recent FOSS release in April 2023. The additional funding will accelerate adoption of BHE and expand research and development initiatives across SpecterOps, including continued work on BloodHound FOSS. BloodHound Enterprise launched in 2021 and experienced rapid customer adoption in 2022, with product revenue growth and new customer acquisition increasing by more than 600%. BHE is used worldwide by organizations such as Capital Group, the University of Texas at Austin and Woodside Energy. The company emphasizes deep knowledge of adversary tradecraft to help clients detect and defend against sophisticated attackers. SpecterOps builds adversary-focused cybersecurity products and services centered on identifying and eliminating identity attack paths in Microsoft Active Directory and Azure AD. Its flagship product, BloodHound Enterprise (launched in 2021), evolved from the widely used BloodHound open-source tool. The company reported rapid customer adoption in 2022, with product revenue growth and new customer acquisition increasing by more than 600%. BloodHound Enterprise is used by organizations including Capital Group, the University of Texas at Austin, and Woodside Energy. SpecterOps also offers services and training, having trained over 6,900 students, assisted more than 185 customers with adversary simulation and detection assessments, contributed 400+ security community contributions, and released 93 open-source security tools. The company plans to expand R&D, product features, consulting and training teams, and open-source development with new funding.